Watch Ticker

Iovance Biotherapeutics, Inc. Common Stock

Go to Iovance Biotherapeutics, Inc. Common Stock Website

$2.75

0.00 (0.00%)

Live

Previous Close

$2.75

Day Range

$0 - $0

Previous Day Range

$2.7 - $2.84

Market Cap

$945.0 million USD

Day Vol.

Previous Day Vol.

8.2 million

Currency

USD

Primary Exchange

Nasdaq

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies persona...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Cory Renauer - This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy?

Iovance Biotherapeutics, a cancer drug developer, received FDA approval for Amtagvi, a cell-based melanoma treatment. Despite a potential 720% price target from one analyst, the stock faces challenges in commercial launch and sales expectations.

Related tickers: IOVA, MRK.

Read Full Article

Prosper Junior Bakiny - This Healthcare Stock Just Hit a 52-Week Low -- but Wall Street Sees 380% Upside

Iovance Biotherapeutics, a biotech company specializing in cancer treatment, shows potential with its innovative Amtagvi medicine for melanoma, but faces significant challenges including reduced revenue guidance, limited treatment center access, and an ongoing securities fraud lawsuit.

Related tickers: IOVA.

Read Full Article

Trending Tickers

Please sign in to view